237 related articles for article (PubMed ID: 32312701)
1. Prospective Evaluation of
Lopci E; Lughezzani G; Castello A; Saita A; Colombo P; Hurle R; Peschechera R; Benetti A; Zandegiacomo S; Pasini L; Casale P; Pietro D; Bevilacqua G; Balzarini L; Buffi NM; Guazzoni G; Lazzeri M
Eur Urol Focus; 2021 Jul; 7(4):764-771. PubMed ID: 32312701
[TBL] [Abstract][Full Text] [Related]
2. Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL).
Wong LM; Sutherland T; Perry E; Tran V; Spelman T; Corcoran N; Lawrentschuk N; Woo H; Lenaghan D; Buchan N; Bax K; Symons J; Saeed Goolam A; Chalasani V; Hegarty J; Thomas L; Christov A; Ng M; Khanani H; Lee SF; Taubman K; Tarlinton L
Eur Urol Oncol; 2024 Jan; ():. PubMed ID: 38281891
[TBL] [Abstract][Full Text] [Related]
3. Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [
Buteau JP; Moon D; Fahey MT; Roberts MJ; Thompson J; Murphy DG; Papa N; Mitchell C; De Abreu Lourenco R; Dhillon HM; Kasivisvanathan V; Francis RJ; Stricker P; Agrawal S; O'Brien J; McVey A; Sharma G; Levy S; Ayati N; Nguyen A; Lee SF; Pattison DA; Sivaratnam D; Frydenberg M; Du Y; Titus J; Lee ST; Ischia J; Jack G; Hofman MS; Emmett L
Eur Urol Oncol; 2024 Jun; 7(3):544-552. PubMed ID: 38061976
[TBL] [Abstract][Full Text] [Related]
4. Targeted Biopsy in Men High Risk for Prostate Cancer:
Pepe P; Pennisi M
Clin Genitourin Cancer; 2023 Dec; 21(6):639-642. PubMed ID: 37394379
[TBL] [Abstract][Full Text] [Related]
5. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT).
Heetman JG; Lavalaye J; Polm PD; Soeterik TFW; Wever L; Paulino Pereira LJ; van der Hoeven EJRJ; van Melick HHE; van den Bergh RCN
Eur Urol Oncol; 2024 Apr; 7(2):204-210. PubMed ID: 37296065
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Prebiopsy Ga-68 PSMA PET/CT in Detecting Primary Prostate Carcinomas with Prostate-Specific Antigen <50 ng/ml.
Chandra P; Rajaian S; Krishnamurthy K; Murugasen L; Chandran G; Kumar JS; Nath S
Indian J Nucl Med; 2020; 35(4):283-290. PubMed ID: 33642751
[TBL] [Abstract][Full Text] [Related]
7. A comparison study of 68gallium-prostate-specific membrane antigen positron emission tomography-computed tomography and multiparametric magnetic resonance imaging for locoregional staging of prostate cancer.
Patel KS; Singh T; Raghuvanshi K; Sonar S; Chaudhari R
Urol Sci; 2024 Mar; 35(1):36-41. PubMed ID: 38566885
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI and
Privé BM; Israël B; Janssen MJR; van der Leest MMG; de Rooij M; van Ipenburg JA; Jonker M; Peters SMB; de Groot M; Zámecnik P; Hoepping A; Bomers JG; Gotthardt M; Sedelaar JPM; Barentsz JO; van Oort IM; Nagarajah J
Radiology; 2024 May; 311(2):e231879. PubMed ID: 38771185
[TBL] [Abstract][Full Text] [Related]
9. The CONFIRM trial protocol: the utility of prostate-specific membrane antigen positron emission tomography/computed tomography in active surveillance for prostate cancer.
Bagguley D; Harewood L; McKenzie D; Ptasznik G; Ong S; Chengodu T; Woon D; Sim K; Sheldon J; Lawrentschuk N
BJU Int; 2024 Apr; 133 Suppl 4():27-36. PubMed ID: 37904302
[TBL] [Abstract][Full Text] [Related]
10. Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
Demirci E; Kabasakal L; Şahin OE; Akgün E; Gültekin MH; Doğanca T; Tuna MB; Öbek C; Kiliç M; Esen T; Kural AR
Nucl Med Commun; 2019 Jan; 40(1):86-91. PubMed ID: 30395048
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Ga-PSMA PET MRI with mpMRI in localization and regional staging of prostate cancer.
Deka H; Pooleri GK; Suguna B; Rajeshkannan R; Sekhar R; Bindhu MR; Prasad V
World J Urol; 2024 Mar; 42(1):153. PubMed ID: 38483621
[TBL] [Abstract][Full Text] [Related]
12. Ductal prostate cancer staging: Role of PSMA PET/CT.
Pepe P; Pepe L; Curduman M; Pennisi M; Fraggetta F
Arch Ital Urol Androl; 2024 Feb; 96(1):12132. PubMed ID: 38363231
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.
Geboers B; Meijer D; Counter W; Blazevski A; Thompson J; Doan P; Gondoputro W; Katelaris A; Haynes AM; Delprado W; O'Neill G; Yuen C; Vis AN; van Leeuwen PJ; Ho B; Liu V; Lee J; Donswijk ML; Oprea-Lager D; Scheltema MJ; Emmett L; Stricker PD
BJU Int; 2024 Apr; 133 Suppl 4():14-22. PubMed ID: 37858931
[TBL] [Abstract][Full Text] [Related]
14. A PSMA PET/CT-based risk model for prediction of concordance between targeted biopsy and combined biopsy in detecting prostate cancer.
An C; Qiu X; Liu B; Song X; Yang Y; Shu J; Fu Y; Wang F; Zhao X; Guo H
World J Urol; 2024 May; 42(1):285. PubMed ID: 38695883
[TBL] [Abstract][Full Text] [Related]
15. The role of PSMA PET/CT in predicting downgrading in patients with Gleason score 4+4 prostate cancer in prostate biopsy.
Aykanat IC; Kordan Y; Seymen H; Koseoglu E; Ozkan A; Esen B; Tarim K; Kulac I; Falay O; Gurses B; Baydar DE; Canda AE; Balbay MD; Demirkol MO; Esen T
World J Urol; 2024 May; 42(1):341. PubMed ID: 38771329
[TBL] [Abstract][Full Text] [Related]
16. Prediction of clinically significant prostate cancer by [
Akcay K; Kibar A; Sahin OE; Demirbilek M; Beydagi G; Asa S; Aghazada F; Toklu T; Selcuk NA; Onal B; Kabasakal L
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1467-1475. PubMed ID: 38112777
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions.
Scobioala S; Kittel C; Wolters H; Huss S; Elsayad K; Seifert R; Stegger L; Weckesser M; Haverkamp U; Eich HT; Rahbar K
Ann Nucl Med; 2021 May; 35(5):628-638. PubMed ID: 33742373
[TBL] [Abstract][Full Text] [Related]
18. The Value of
Shi J; Li D; Chen M; Fu Y; Peng S; Zhang Q; Liang J; Lu Q; Lu J; Ai S; Wang F; Qiu X; Guo H
J Nucl Med; 2024 Apr; 65(4):555-559. PubMed ID: 38485278
[TBL] [Abstract][Full Text] [Related]
19. Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
Büttner T; Gärtner F; Essler M; Weiten R; Kristiansen G; Ellinger J; Ritter M; Krausewitz P
Prostate; 2024 Jun; 84(8):772-779. PubMed ID: 38504659
[TBL] [Abstract][Full Text] [Related]
20. THE DIAGNOSTIC ACCURACY OF A COMBINATION OF PREOPERATIVE 68-Ga PSMA PET/CT AND MULTIPARAMETRİC MRI IN LOCALIZED PROSTATE CANCER.
Simsek A; Celen S; Duran MB; Kucuker K; Yagci AB; Sen Turk N; Yuksel D; Turan T
Urol Int; 2024 Mar; ():. PubMed ID: 38479370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
